Salet

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Salet

What is Salet? A Gastrointestinal Protectant

Property Description
Active ingredient Sucralfate (Basic Aluminum Salt of Sucrose Octasulfate)
Form Tablet and Oral Suspension
Pharmacological class Gastrointestinal Protectant / Antiulcer Agent
General purpose Protects the lining of the stomach and intestine from aggressive agents
Origin Synthetic derivative

What Type of Medicine is Salet (Sucralfate)?

Salet is a prescription antiulcer agent classified pharmacologically as a Gastrointestinal Protectant and a Miscellaneous Gastrointestinal Agent. Its single active ingredient is Sucralfate, a unique compound designed to shield the digestive tract. This medicine is clinically recognized for its effectiveness in providing physical protection and supporting the healing of irritated or damaged tissue in the esophagus, stomach, and intestine. It serves an established role as an agent for protecting the mucosal barrier.

Composition and Forms: A Synthetic Protective Salt

The active component, Sucralfate, is a synthetic derivative—specifically, a complex aluminum salt prepared from sucrose and sulfur. It is a single-ingredient product designed for oral administration and is available in two main dosage forms: a solid tablet and a liquid oral suspension. The suspension form is often utilized when a thorough coating of the upper gastrointestinal tract is desired, which represents a key feature in delivery. Sucralfate is characterized by a high affinity for ulcerated tissue.

How Salet Provides General Gastrointestinal Support

Salet works by forming an ulcer-adherent complex, effectively creating a protective barrier or "bandage" that sticks directly to the damaged areas of the mucosal lining. This unique site-protective effect physically shields the vulnerable tissue from further damage by corrosive factors like gastric acid, pepsin, and bile salts. This mechanism of action is crucial for its typical use in settings where protection is needed against chemical irritation. By establishing this protective film, the medicine helps to mitigate local injury and creates a low-irritation environment, essential for the body's natural processes of tissue repair and regeneration to proceed.

Regulatory References

  1. MedlinePlus Drug Information

What side effects are possible with Salet?

Possible Side Effects and Safety Information

The official safety profile for Salet (Sucralfate) is primarily characterized by localized effects in the digestive system, reflecting the medicine's minimal systemic absorption. Adverse reactions are grouped by frequency and the body system affected, consistent with regulatory standards from authorities like the EMA and FDA.


Adverse Reaction Classification

Classification Examples of Officially Listed Adverse Reactions
Common Constipation (the most frequently reported reaction)
Uncommon Dry mouth, nausea, diarrhea, rash, pruritus (itching)
Rare Dizziness, headache, somnolence, bezoar formation

The majority of reported effects are classified under Gastrointestinal Disorders. Less frequent reactions may be noted in Nervous System Disorders and Skin and Subcutaneous Tissue Disorders.


Serious Safety Considerations

Safety documents list the risk of Aluminum Accumulation and related toxicity (e.g., neurotoxicity) as a serious concern. This systemic risk is explicitly associated with long-term use, particularly in patients with chronic renal failure or those on dialysis, due to impaired aluminum excretion. These populations are noted to be at a significantly increased risk and require careful monitoring.

Additionally, the rare but serious event of bezoar formation (a gastric mass) is documented, particularly in individuals with pre-existing impaired gastrointestinal motility. The medicine may also bind with other orally administered drugs, a safety note concerning the absorption of concomitant medications.

Overdose and Emergency Response

Overdose and When to Seek Help

Note: The substance Tianeptine, often associated with products named 'Salet,' is not approved for any medical use by the U.S. Food and Drug Administration (FDA) and has been explicitly linked to serious risks, including overdose and death.

Official Overdose Profile and Emergency Action

Official regulatory documents describe that abuse or misuse of Tianeptine has been associated with serious harmful effects, and the resulting clinical manifestations can mimic opioid toxicity.

Documented Overdose Presentations:

System Manifestations
Neurological Agitation, confusion, drowsiness, coma
Cardiovascular Rapid heartbeat, high blood pressure
Respiratory Slowed or stopped breathing
Other Sweating, nausea, vomiting

Overdose Risk Factors: Reports have described consumers taking daily doses significantly higher than those typically recommended in other countries where the substance is approved. Individuals with a history of opioid dependence may be at particular risk of abuse.

When Immediate Medical Help is Required:

Regulatory authorities explicitly warn consumers to avoid all products containing Tianeptine. If poisoning or an overdose is suspected, immediate emergency action is necessary. Contact the Poison Help Line (1-800-222-1222) without delay.

Therapeutic Uses of Salet

Quick Facts

  • Primary Use: May help manage high blood pressure (hypertension).
  • Secondary Use: May be prescribed to support heart function in individuals with heart failure.
  • Potential Benefit: May assist in reducing the likelihood of certain cardiovascular events.

Salet is a prescription medication utilized to support the management of specific cardiovascular conditions. The primary therapeutic domain for Salet is the management of high blood pressure (hypertension). Maintaining blood pressure at appropriate levels may help support the health of blood vessels and organs over time.

Additionally, Salet may be used to provide support for patients with heart failure. In this setting, the medication is intended to ease the demands on the heart and may help alleviate associated symptoms. For individuals who have experienced a heart attack, the treatment may also be prescribed to support the reduction of the likelihood of related cardiovascular events, as determined by a healthcare professional. These uses and benefits are established for this class of treatments.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Salet (Sodium Chloride) is a medicine for patients with documented sodium chloride deficiency. Its use is defined by official regulatory bodies through specific eligibility and contraindication rules.

Populations Not Eligible (Contraindications)

Use is contraindicated in patients with a known hypersensitivity to the active substance or any excipient. It must also not be used in any clinical state where salt retention is undesirable, which formally includes patients with:

  • Oedema (fluid retention)
  • Heart disease or cardiac decompensation
  • Primary or secondary aldosteronism

It is also forbidden when the goal of current therapy is to promote salt and water loss (diuresis).

Restricted Use and Special Consideration

Population Group Eligibility Status/Classification
Gastrointestinal Risk Not Recommended in intestinal conditions where strictures or diverticula may form, due to the risk of tablet obstruction.
Children Permitted, but dosage must be adjusted to individual needs by a healthcare provider.
Elderly Permitted, with no special dosage adjustment generally required.
Pregnancy/Lactation Permitted, as use at therapeutic doses is not expected to cause adverse effects.

All patients must be advised to swallow the tablets whole and ensure adequate fluid intake to avoid elevated sodium levels in the blood.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The primary interaction pattern for Salet (Sucralfate) is a non-systemic pharmacokinetic interaction that occurs within the gastrointestinal tract. This involves physicochemical binding that results in the reduced extent of absorption (bioavailability) of other co-administered oral medications, as stated in regulatory labeling.

To mitigate this effect, official documents require timing separation for several drugs. For example, certain oral medications that are sensitive to altered bioavailability—including Cimetidine, Digoxin, and Fluoroquinolone antibiotics (e.g., Ciprofloxacin)—should be administered two hours before Sucralfate. Antacids, which are also aluminum-containing products, should not be taken within one-half hour (30 minutes) before or after Salet administration.

Aluminum Burden and Population-Specific Risk

Sucralfate is an aluminum salt, which dictates specific interaction concerns related to aluminum burden. Concomitant use with other aluminum-containing products or citrate preparations may increase the total body burden of aluminum.

This risk is especially noted in regulatory documents for patients with chronic renal failure or those on dialysis. In this population, the impaired excretion of absorbed aluminum can lead to aluminum accumulation and toxicity, such as osteodystrophy and encephalopathy.

Mechanism of Action

The mechanism of Salet (Sucralfate) is defined by its ability to create a highly localized protective environment that functionally facilitates mucosal repair processes. This action begins with the acid-dependent polymerization of the drug into a large, viscous, negatively charged anion upon entering an acidic environment ( pH < 4). This polymer then exhibits a high electrostatic affinity for positively charged proteins, such as fibronectin and albumin, which are exposed in damaged gastrointestinal tissue. This adhesion results in the formation of a stable, physical barrier that isolates the injury site. The barrier actively adsorbs and traps aggressive luminal components, specifically restricting the diffusion of hydrogen ions ( H^+) and binding the proteolytic enzyme Pepsin. This contributes to a reduction in the proteolytic and chemical burden imposed by luminal factors, functionally interrupting the cycle of tissue injury. The resultant stability indirectly promotes the enhanced concentration and function of endogenous healing mediators, including Epidermal Growth Factor (EGF) and locally produced Prostaglandins ( PGE2), a physiological effect that facilitates re-epithelialization and mucosal regeneration by stabilizing the local environment.

Dosage and Administration Information

How to Use Salet (Sucralfate): Administration Guidelines

Salet, whose active ingredient is Sucralfate, is administered exclusively via the oral route using either the 1 gram tablet or the 1 gram per 10 mL oral suspension. The standard unit dose is 1 gram per administration, which is utilized for both the initial active ulcer treatment and subsequent maintenance therapy.

The administration schedule is established for therapeutic use. For the active treatment course, the medicine is typically taken four times daily (QID), with the duration usually spanning 4 to 8 weeks. For long-term use intended to prevent recurrence, the schedule shifts to twice daily (BID).

A critical instruction for proper use is the timing relative to food and other medications. Sucralfate must be taken on an empty stomach, meaning it is administered approximately one hour before each main meal and at bedtime. To avoid interference with its activation, administration must also be separated from antacids, typically by 30 minutes. If using the suspension, the product requires thorough shaking before each dose. While standard adult dosing is outlined, caution is needed in individuals with renal impairment due to the aluminum content. The instructions define a specific procedural pattern of use rather than an episodic one.

Recent Clinical Evidence

The availability of recent clinical evidence for Salet requires confirmation, as the drug name 'Salet' does not appear in current, publicly accessible databases for approved medications or ongoing clinical trials registered by major regulatory bodies, such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA).

Clinical evidence summaries are typically based on the results of controlled trials (Phase 1, 2, and 3 studies) designed to evaluate a medication's safety profile, efficacy for specific conditions, and optimal dosage. These studies are registered on platforms like ClinicalTrials.gov (National Institutes of Health) to maintain transparency and provide access to peer-reviewed data and results for the medical community and the public.

Without documented, completed clinical trials or official regulatory approval data, no specific claims regarding the performance, safety profile, or therapeutic outcomes of Salet can be provided. Patients and healthcare professionals should rely only on information that is substantiated by published medical literature and official drug labeling information provided by the regulatory agency that approved the medication for use in their region. Any drug information claiming to present clinical evidence must be traceable to high-quality, reputable sources to ensure accuracy and patient safety.

Summary of Evidence Requirements

Data Type Standard Requirement
Efficacy Results from randomized, placebo-controlled trials.
Safety Profile Long-term data on adverse events and serious risks.
Status Official approval or trial registration on NIH/EMA/FDA platforms.

Frequently Asked Questions (FAQ)

Common questions about Salet (FAQ)


Q: Is Salet the same as [other common drug name]?

A: Official drug documents classify Salet (Sucralfate) as a Gastrointestinal Protectant and an Antiulcer Agent. Its mechanism of action, which involves forming a physical barrier over damaged tissue, differs from other common treatments such as acid-reducing drugs. This means it functions in a unique way to support healing.


Q: How quickly should I expect Salet to start working?

A: According to official product information, the protective action of Salet begins relatively quickly. The formation of the physical barrier, which shields the damaged tissue, is described as occurring within 1 to 2 hours after oral administration. This occurs when the medicine reaches the required environment in the stomach and begins to activate.


Q: Can Salet be taken with common over-the-counter pain relievers?

A: Regulatory documents state that Salet may reduce the absorption (bioavailability) of many other oral medications through binding in the digestive tract. To avoid this potential interaction, the drug label generally requires other medications to be taken 2 hours before Salet. Patients are advised to refer to the official drug label or consult a healthcare professional for specific timing separation.


Q: How long does Salet stay in your system after the last use?

A: Salet acts locally and is minimally absorbed into the bloodstream; only about 5% of the dose enters the system. The functional duration of the protective action at the ulcer site is described in official information as lasting for up to 6 hours. The small portion that is absorbed is eliminated primarily through the urine.


Q: Is Salet recommended for people with kidney issues?

A: Official documents note that use requires caution in patients with renal failure (kidney impairment) or those undergoing dialysis. Because Salet is an aluminum salt, impaired kidney function can increase the potential for aluminum to accumulate in the body. Official documents state that patients in these populations require careful observation.


Q: Can I use Salet if I have diabetes?

A: Official regulatory summaries advise that patients with diabetes should check their blood sugar levels regularly while using the medicine. Official summaries indicate that hyperglycemia (high blood sugar) has been reported as an adverse effect, which is why regular checks are important.


Q: What is the purpose of the filler ingredients in the Salet pill?

A: In official regulatory terms, the non-active components are called excipients. These ingredients are necessary to manufacture the medicine into a stable form, such as a tablet or suspension, and to ensure proper delivery. These components do not provide therapeutic action on their own.


Q: Is Salet used to treat chronic conditions?

A: Yes, official labeling describes two main uses. After the initial treatment, Salet is approved for Maintenance Therapy to prevent the recurrence of healed duodenal ulcers. This long-term use is consistent with therapies intended to manage conditions that are long-lasting or recurring.


Q: Does Salet have any impact on mood?

A: Official adverse effects data indicates that effects on the central nervous system (CNS) are rare. The adverse effect list includes Insomnia (difficulty sleeping) in less than 1% of patients. Mood changes are not specifically listed among the common adverse effects reported in official documents.


Q: Can Salet affect my sleep schedule?

A: The official product information lists two potential effects that may relate to sleep. Insomnia (difficulty sleeping) and somnolence (drowsiness or sleepiness) are documented as adverse effects, though they are reported in less than 0.5% of patients in clinical data.


Q: Are there any specific foods I should avoid while on Salet?

A: Official patient information indicates that no specific foods are known to interact with Salet, as it is minimally absorbed by the body. However, the medicine is directed to be taken on an empty stomach (separated from meals) for it to form its protective barrier effectively.


Q: Is Salet a controlled substance or addictive?

A: Official sources, including those that categorize drug scheduling, confirm that the active ingredient, Sucralfate, is not classified as a controlled substance. The medicine is not known to be habit-forming or addictive.


Q: Can I drink coffee while taking Salet?

A: Official data does not report a direct chemical interaction between Salet and the compounds found in coffee or caffeine. However, the drug is required to be taken on an empty stomach and separate from meals and beverages for the medicine to form its protective barrier effectively.


Q: Can Salet be crushed or split?

A: Official warnings state that the tablet form should be used with caution in patients who have pre-existing conditions that may impair swallowing or affect the digestive tract. The standard guidance is to use the tablet form as prescribed and to follow the specific instructions provided by the prescribing professional.


Q: Why does the duration of use for Salet vary so much?

A: The duration of use is different because the medicine is used for two distinct treatment goals. The short-term use (typically 4 to 8 weeks) is for active treatment to help a current ulcer heal. The long-term use (maintenance therapy) is designed to prevent recurrence of the ulcer once it has healed.


Q: What if I miss a use of Salet?

A: Official patient information often describes a common strategy: if a dose is missed, it is generally advised to take it as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped entirely, and the regular schedule should be continued.

How should Salet be stored and disposed of?

How to Store and Dispose of Salet (Sucralfate)

Official regulatory labeling dictates specific storage and disposal requirements for Salet (Sucralfate) to ensure product stability and patient safety.

Storage Requirements

Requirement Details
Temperature Store at Controlled Room Temperature, 20^circC to 25^circC (68^circF to 77^circF).
Protection Keep the product out of the reach of children and protected from excess heat and moisture.
Handling The oral suspension form must not be frozen.
Container The container must be kept tightly closed when not in use.

Disposal Requirements

To discard unused or expired medication, do not throw away Salet via wastewater or household waste. Consult a pharmacist or local waste disposal company for guidance on appropriate disposal methods, which must comply with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Salet found in:

A-Z Index: